Skip Navigation



NDT Advance Access published online on July 26, 2005

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi022
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/11/2414    most recent
gfi022v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Orth, S. R.
Right arrow Articles by Ferrari, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orth, S. R.
Right arrow Articles by Ferrari, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received June 15, 2005
Accepted June 22, 2005


Original Articles

Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus

Stephan R. Orth 1, Torsten Schroeder 2, Eberhard Ritz 2, and Paolo Ferrari 3*

1 Klinik und Poliklinik für Innere Medizin II - Nephrologie, University of Regensburg, Regensburg, Germany
2 Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
3 Department of Nephrology, Fremantle Hospital, University of Western Australia, Perth, Australia

* To whom correspondence should be addressed.
Paolo Ferrari, E-mail: paolo.ferrari{at}health.wa.gov.au



  Abstract

Background. Smoking increases the risk of end-stage renal failure in patients with primary renal disease. Whether and to what extent smoking affects the kidneys in diabetic patients with normal renal function and variable degrees of proteinuria has not been fully studied.

Methods. We followed 185 patients with type 1 or 2 diabetes mellitus and with or without signs of overt renal disease for at least 3 years, median 5.1 (3-6.8) years. Each patient had a baseline visit and at least four follow-up visits (average 4.8±0.3). Cases were patients who were smoking (n = 44) at the time the survey was started. Controls were patients who had never smoked (n = 141). Glomerular filtration rate (GFR) was estimated using the MDRD formula. Multiple logistic regression was used to correct for confounding factors.

Results. At baseline, smokers were younger (47±14 vs 54±16 years, P<0.01), and had a lower GFR (95±26 ml/min) than non-smokers (107±33 ml/min, P<0.05). Mean GFR remained constant during follow-up in non-smokers (106±31 ml/min), but decreased significantly in smokers (83±22 ml/min, P<0.0001), and this relationship persisted when adjusted for retinopathy, glycaemic control, age, body habitus, ACE-inhibitor treatment, blood pressure control or severity of proteinuria. The effect of smoking on GFR decline was stronger in patients with type 1 diabetes or male gender.

Conclusions. Cigarette smoking causes a decrease in GFR in diabetic patients with normal or near-normal renal function, independent of confounding factors including severity of proteinuria. The latter finding suggests a mechanism independent of glomerular damage.

Keywords: diabetes; nephropathy; progression; proteinuria; smoking.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
S. R. Orth and S. I. Hallan
Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Saito, H. Sone, K. Kawai, S. Tanaka, S. Kodama, M. Shu, E. Suzuki, K. Kondo, S. Yamamoto, H. Shimano, et al.
Risk Imparted by Various Parameters of Smoking in Japanese Men With Type 2 Diabetes on Their Development of Microalbuminuria: Analysis from the Tsukuba Kawai Diabetes Registry
Diabetes Care, May 1, 2007; 30(5): 1286 - 1288.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. J. Elliot, M. Karl, M. Berho, X. Xia, S. Pereria-Simon, D. Espinosa-Heidmann, and G. E. Striker
Smoking Induces Glomerulosclerosis in Aging Estrogen-Deficient Mice through Cross-Talk between TGF-beta1 and IGF-I Signaling Pathways
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3315 - 3324.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. De Cosmo, O. Lamacchia, A. Rauseo, R. Viti, L. Gesualdo, A. Pilotti, V. Trischitta, and M. Cignarelli
Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes.
Diabetes Care, November 1, 2006; 29(11): 2467 - 2470.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. Nakamura, T. Sugaya, and H. Koide
Cigarette Smoking Affects Urinary Liver-Type Fatty Acid-Binding Protein Concentration in Patients With Early Diabetic Nephropathy
Diabetes Care, July 1, 2006; 29(7): 1717 - 1717.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.